- Home
- MLP vs VYGR Comparison
MLP vs VYGR Comparison
Compare MLP & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- VYGR
- Stock Information
- Founded
- MLP 1909
- VYGR 2013
- Country
- MLP United States
- VYGR United States
- Employees
- MLP N/A
- VYGR 162
- Industry
- MLP Real Estate
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- MLP Finance
- VYGR Health Care
- Exchange
- MLP Nasdaq
- VYGR Nasdaq
- Market Cap
- MLP 411.7M
- VYGR 297.7M
- IPO Year
- MLP 1972
- VYGR 2015
- Fundamental
- Price
- MLP $20.14
- VYGR $5.45
- Analyst Decision
- MLP
- VYGR Strong Buy
- Analyst Count
- MLP 0
- VYGR 9
- Target Price
- MLP N/A
- VYGR $15.53
- AVG Volume (30 Days)
- MLP 21.7K
- VYGR 356.0K
- Earning Date
- MLP 03-27-2025
- VYGR 02-26-2025
- Dividend Yield
- MLP N/A
- VYGR N/A
- EPS Growth
- MLP N/A
- VYGR N/A
- EPS
- MLP N/A
- VYGR 0.47
- Revenue
- MLP $12,196,000.00
- VYGR $163,784,000.00
- Revenue This Year
- MLP N/A
- VYGR N/A
- Revenue Next Year
- MLP N/A
- VYGR N/A
- P/E Ratio
- MLP N/A
- VYGR $11.69
- Revenue Growth
- MLP 34.84
- VYGR 3.40
- 52 Week Low
- MLP $18.50
- VYGR $4.99
- 52 Week High
- MLP $26.46
- VYGR $10.66
- Technical
- Relative Strength Index (RSI)
- MLP 46.14
- VYGR 45.02
- Support Level
- MLP $19.37
- VYGR $5.32
- Resistance Level
- MLP $21.34
- VYGR $5.76
- Average True Range (ATR)
- MLP 0.85
- VYGR 0.27
- MACD
- MLP 0.19
- VYGR 0.05
- Stochastic Oscillator
- MLP 56.68
- VYGR 47.42
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.